LIVINGSTON, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that it will be exhibiting at the upcoming Chicago Dental Society's 144th Midwinter Meeting in Chicago. In light of its highly successful sales of the STA Single Tooth Anesthesia System(TM) at last year's CDS conference, coupled with four successive quarters of sales growth in 2008, Milestone anticipates an enthusiastic reception at this year's event.
WHEN: Thursday, February 26, 2009 - Sunday, March 1, 2009 WHERE: Booth #2206 McCormick Place Lakeside Center 2301 South Lake Shore Drive Chicago, Illinois WHO: Joe Martin, Chief Executive Officer Bob Presutti, Vice President of Sales & Marketing Scott Mahnken, Director of Marketing WHAT: Demonstrations of the STA Single Tooth Anesthesia System(TM) (STA System)
Members of the press must register at the Press Booth for this event. For details on obtaining Press Credentials, please visit: http://www.cds.org/media. To book a one-on-one meeting or demonstration, please contact Kathy Addison or Tiffany Korkis at Elite Media Group by calling 407-585-1080 or via email at email@example.com.
The Midwinter Meeting is among the top three dental meetings in the U.S. and one of the top 10 conventions in Chicago. Each year, more than 600 exhibiting companies participate in the meeting, creating one of the largest exhibits of dental products and manufacturers in North America. The theme for the 2009 Midwinter Meeting is "The World of Dental Networking". The 2008 Midwinter Meeting drew more than 34,500 attendees to the city of Chicago, including 7,515 dentists.
About the Chicago Dental Society
The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit their Web site at http://www.cds.org/.
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System, a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milesci.com and www.STAis4U.com.
Safe Harbor Statement
This press release may contain forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
FOR MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications Group Dodi Handy, President and CEO For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite Media Group 407-585-1080 or via email at firstname.lastname@example.org
|SOURCE Milestone Scientific Inc.|
Copyright©2009 PR Newswire.
All rights reserved